NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 Sunstone Hotel Investors Inc SHO Q1 2026 Earnings EPS Surges Past Estimates Despite Flat Revenue Disclosure OPLN Q1 2026 Earnings EPS Beats Estimates by 124 Stock Rises LSBK Q3 2025 Earnings EPS of 032 Stands Alone Amid Sparse Disclosure YMM Q1 2026 Earnings Strong EPS Beat Masks Revenue Concerns as Stock Slips Allbirds Q1 2026 Earnings Deeper Losses and Investor Caution Amid Restructuring UHT Q1 2026 Earnings EPS Beats in Absence of Consensus Shares Edge Higher FOA Q1 2026 Earnings Strong EPS Surprise of 2966 Drives Investor Attention Immunic Q1 2026 Earnings EPS Miss but Stock Surges 6 as Clinical Progress May Lift Sentiment Addentax Group Corp ATXG Q1 2025 Earnings Loss Reported Amid Minimal Market Reaction NWFL Q1 2026 Earnings Strong EPS Beat Amid Challenging Environment CRVS Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development